Abstract
The progression of disease in patients with systemic lupus erythematosus (SLE) is affected by production, accumulation, and actions of cytokines. Type I interferon (IFN), specifically IFN-α, is recognized as a central mediator of disease pathogenesis in SLE. We describe a functional assay to measure type I IFN activity in SLE plasma and have also measured the response of peripheral blood cells to that cytokine family. This method can be scaled to assess IFN functional activity, as well as activity and cellular response to other cytokines, in relation to cellular and serologic parameters relevant to SLE.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Becker-Merok A, Østli-Eilersten G, Lester S et al (2013) Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation. Lupus 22:155–163
Crow MK, Wohlgemuth J (2003) Microarray analysis of gene expression in lupus. Arthritis Res Ther 5:279–287
Bennett L, Palucka a K, Arce E et al (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711–723
Nzeusseu Toukap A, Galant C, Theate I et al (2007) Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum 56:1579–1588
Crow MK (2010) Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheum Dis Clin North Am 36:173–186
Lövgren T, Eloranta M-L, Båve U et al (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50:1861–1872
Crow MK (2008) Collaboration, genetic associations, and lupus erythematosus. N Engl J Med 358:956–961
Wang C, Sandling JK, Hagberg N et al (2013) Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4. Ann Rheum Dis 72:96–103
Connolly JJ, Hakonarson H (2012) Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing. J Biomed Biotechnol 2012:1–17
Mikita N, Ikeda T, Ishiguro M et al (2011) Recent advances in cytokines in cutaneous and systemic lupus erythematosus. J Dermatol 38: 839–849
Poole BD, Niewold TB, Tsokos GC (2012) Cytokines in systemic lupus erythematosus 2011. J Biomed Biotechnol 2012:427824
Su D-L, Lu Z-M, Shen M-N et al (2012) Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol 2012:347141
Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611–622
Overbergh L, Giulietti A, Valckx D et al (2003) The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14:33–43
Boeuf P, Vigan-Womas I, Jublot D et al (2005) CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol 6:5
Brazma A, Hingamp P, Quackenbush J (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29(4):365–371
Gentleman RC, Carey VJ, Bates DM et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57
Samarajiwa SA, Forster S, Auchettl K et al (2009) INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res 37:D852–D857
Seo Y-J, Kim G-H, Kwak H-J et al (2009) Validation of a HeLa Mx2/Luc reporter cell line for the quantification of human type I interferons. Pharmacology 84:135–144
Bürgi M, Prieto C, Etcheverrigaray M et al (2012) WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β. J Immunol Methods 381:70–74
Hua J, Kirou K, Lee C et al (2006) Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 54:1906–1916
Yousefi S, Escobar MR, Gouldin CW (1985) A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory. Am J Clin Pathol 83:735–740
Hayflick L (1961) The establishment of a line (WISH) of human amnion cells in continuous cultivation. Exp Cell Res 23:14–20
Nelson-Rees WA, Flandermeyer RR (1976) HeLa cultures defined. Science (New York, NY) 191:96–98
Chen TR (1988) Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenet Cell Genet 48:19–24
Nalbandian A, Crispín JC, Tsokos GC (2009) Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 157:209–215
Novick D, Elbirt D, Miller G et al (2010) High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun 34:121–126
Okamoto H, Katsumata Y, Nishimura K et al (2004) Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum 50:3731–3732
Vega L, Barbado J, Almansa R et al (2010) Prolonged standard treatment for systemic lupus erythematosus fails to normalize the secretion of innate immunity-related chemokines. Eur Cytokine Netw 21:71–76
López P, Gómez J, Prado C et al (2008) Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. J Rheumatol 35:1559–1566
Park YB, Lee SK, Kim DS et al (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheum 16:283–288
George-Chandy A, Trysberg E, Eriksson K (2008) Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res Ther 10:R97
Sarra M, Monteleone G (2010) Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus. J Biomed Biotechnol 2010:294582
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Olferiev, M., Lliguicota, M., Kirou, K.A., Crow, M.K. (2014). Measuring Interferon Alpha and Other Cytokines in SLE. In: Eggleton, P., Ward, F. (eds) Systemic Lupus Erythematosus. Methods in Molecular Biology, vol 1134. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0326-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0326-9_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0325-2
Online ISBN: 978-1-4939-0326-9
eBook Packages: Springer Protocols